Klabax Ec

Clarithromycin, the active ingredient in Klabax Ec, is a macrolide antibiotic presented as a tablet for oral use. It treats a range of bacterial infections in adults and children, including respiratory and skin infections.

GNH USA supplies Klabax Ec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clarithromycin is a macrolide antibiotic used to treat bacterial infections affecting various organ systems.

- Community‑acquired pneumonia: eradicates the causative bacteria and improves respiratory function. - Acute bacterial sinusitis: reduces sinus inflammation and clears infection. - Acute exacerbations of chronic bronchitis: shortens symptom duration and prevents complications. - Skin and soft‑tissue infections: eliminates pathogenic bacteria and promotes healing. - Helicobacter pylori eradication (in combination therapy): contributes to ulcer healing and reduces recurrence.

Clarithromycin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: frequent loose stools. - Abdominal pain: cramping or discomfort. - Taste disturbance: altered or metallic taste. - Headache: mild to moderate pain. - Vomiting: occasional episodes.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, anaphylaxis. - QT interval prolongation: risk of cardiac arrhythmias. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Clostridioides difficile colitis: severe diarrhea. - Stevens‑Johnson syndrome: serious skin reaction.

Before initiating clarithromycin therapy, consider the following precautions.

- Liver function assessment: monitor hepatic enzymes in patients with liver disease. - Cardiac monitoring: avoid in patients with known QT prolongation or taking other QT‑prolonging drugs. - Renal impairment: dose adjustment may be required for severe kidney dysfunction. - Allergy screening: do not use in individuals with known macrolide hypersensitivity. - Drug interaction review: evaluate concomitant medications that may interact. - Store at room temperature: keep in the original packaging, protect from moisture and heat.

Clarithromycin interacts with several medications; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid): - Cisapride and pimozide: risk of serious cardiac arrhythmias. - Simvastatin and other CYP3A4 substrates: increased risk of myopathy. - Ergot alkaloids: potential for ergotism. - Colchicine: heightened toxicity, especially in renal impairment. - Warfarin: enhanced anticoagulant effect, increased INR.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduction in efficacy. - Carbamazepine and phenytoin: decreased clarithromycin levels. - Digoxin: modest increase in serum concentration. - Theophylline: potential for elevated theophylline levels. - Antacids containing aluminum or magnesium: may reduce absorption.